Overview Financials News + Filings Key Docs Ownership Insiders
|
NP Life Sciences Health Industry Group Inc. (GJCU)
|
|
Income Statement |
|
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K |
Revenues: |
Customer B | | | 0.0 |
Customer A | | | 0.0 |
Total revenues | 0.0 | 0.0 | 0.0 |
Revenue growth | 133.3% | -65.1% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 |
Gross margin | 100.0% | 100.0% | 100.0% |
Selling, general and administrative [+] | 0.1 | 0.1 | 0.2 |
General and administrative | 0.1 | 0.1 | 0.2 |
EBITA | -0.1 | -0.1 | -0.1 |
EBITA margin | -187.7% | -863.5% | -249.8% |
Amortization of intangibles | | 0.0 | 0.0 |
EBIT [+] | -0.1 | -0.1 | -0.1 |
EBIT growth | -49.9% | 20.4% | |
EBIT margin | -187.7% | -873.9% | -253.2% |
Interest income | 0.0 | 0.0 | 0.0 |
Interest income | 0.0 | 0.0 | 0.0 |
Pre-tax income | -0.1 | -0.1 | -0.1 |
Income taxes | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% |
Net income | -0.1 | -0.1 | -0.1 |
Net margin | -187.7% | -873.8% | -253.1% |
|
Basic EPS [+] | $0.00 | $0.00 | $0.00 |
Growth | -49.9% | -4.3% | |
Diluted EPS [+] | $0.00 | $0.00 | $0.00 |
Growth | -49.9% | -4.3% | |
|
Shares outstanding (basic) [+] | 43.0 | 43.0 | 34.1 |
Growth | 0.0% | 25.9% | |
Shares outstanding (diluted) [+] | 43.0 | 43.0 | 34.1 |
Growth | 0.0% | 25.9% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|